People News

Share this article:

Xanodyne Pharmaceuticals, a specialty pharma focused on women's healthcare and pain management, announced the appointment of Michael Valentino to president and CEO. Valentino was previously president and CEO at Adams Laboratories. Before that, he was EVP, global head, consumer pharmaceuticals at Novartis.

 

Astellas hired Betsy Garofalo as global therapy leader for its central nervous system (CNS) group. Garofalo, a pediatric neurologist and epileptologist, will “provide strategic direction and leadership for the development of all Astellas CNS compounds,” said Steven Ryder, president of Astellas Pharma Global Development, in a statement. Garofalo is an adjunct associate professor of pediatrics at the University of Michigan, and has previously worked at Pfizer R&D, and Parke-Davis.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in People Moves

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters